Nanomedicine Market Report

Nanomedicine Market Analysis By Products (Therapeutics, Regenerative Medicine, Diagnostics), By Application (Clinical Oncology, Infectious diseases), By Nanomolecule (Gold, Silver, Iron Oxide, Alumina), & Segment Forecasts, 2020 - 2025

  • Report ID: 978-1-68038-942-5
  • Number of Pages: 165
  • Format: Electronic (PDF)
  • Historical Range: 2013 - 2018
  • Industry: Healthcare

Market Segmentation

  • Nanomedicine Product Outlook (Revenue, USD Billion, 2013 - 2025)
    • Therapeutics
    • Regenerative medicine
    • In-vitro diagnostics
    • In-vivo diagnostics
    • Vaccines
  • Nanomedicine Application Outlook (Revenue, USD Billion, 2013 - 2025)
    • Clinical Oncology
    • Infectious diseases
    • Clinical Cardiology
    • Orthopedics
    • Others
  • Nanomedicine Nanomolecule Type Outlook (Revenue, USD Billion, 2013 - 2025)
    • Nanoparticles
      • Metal & Metal Oxide Nanoparticles
        • By Type
          • Gold Nanoparticles
          • Silver Nanoparticles
          • Iron Oxide Nanoparticles
          • Alumina Nanoparticles
          • Gadolinium Oxide Nanoparticles
          • Others
        • By Application
          • In-vivo Imaging
          • Targeted Drug Delivery
          • Proton Therapy
          • In-vitro assays
          • Cell & Phantom Imaging
      • Liposomes
      • Polymers & polymer drug conjugates
      • Hydrogel nanoparticles
      • Dendrimers
      • Inorganic nanoparticles
    • Nanoshells
    • Nanotubes
    • Nanodevices
  • Nanomedicine Regional Outlook (Revenue, USD Billion, 2013 - 2025)
    • North America
      • The U.S.
        • U.S. Product Outlook (Revenue, USD Billion, 2013 - 2025)
          • Therapeutics
          • Regenerative medicine
          • In-vitro diagnostics
          • In-vivo diagnostics
          • Vaccines
        • U.S. Application Outlook (Revenue, USD Billion, 2013 - 2025)
          • Clinical Oncology
          • Infectious diseases
          • Clinical Cardiology
          • Orthopedics
          • Others
        • U.S. Nanomolecule Type Outlook (Revenue, USD Billion, 2013 - 2025)
          • Nanoparticles
            • Metal & Metal Oxide Nanoparticles
              • By Type
                • Gold Nanoparticles
                • Silver Nanoparticles
                • Iron Oxide Nanoparticles
                • Alumina Nanoparticles
                • Gadolinium Oxide Nanoparticles
                • Others
              • By Application
                • In-vivo Imaging
                • Targeted Drug Delivery
                • Proton Therapy
                • In-vitro assays
                • Cell & Phantom Imaging
            • Liposomes
            • Polymers & polymer drug conjugates
            • Hydrogel nanoparticles
            • Dendrimers
            • Inorganic nanoparticles
          • Nanoshells
          • Nanotubes
          • Nanodevices
      • Canada
        • Canada Product Outlook (Revenue, USD Billion, 2013 - 2025)
          • Therapeutics
          • Regenerative medicine
          • In-vitro diagnostics
          • In-vivo diagnostics
          • Vaccines
        • Canada Application Outlook (Revenue, USD Billion, 2013 - 2025)
          • Clinical Oncology
          • Infectious diseases
          • Clinical Cardiology
          • Orthopedics
          • Others
        • Canada Nanomolecule Type Outlook (Revenue, USD Billion, 2013 - 2025)
          • Nanoparticles
            • Metal & Metal Oxide Nanoparticles
              • By Type
                • Gold Nanoparticles
                • Silver Nanoparticles
                • Iron Oxide Nanoparticles
                • Alumina Nanoparticles
                • Gadolinium Oxide Nanoparticles
                • Others
              • By Application
                • In-vivo Imaging
                • Targeted Drug Delivery
                • Proton Therapy
                • In-vitro assays
                • Cell & Phantom Imaging
            • Liposomes
            • Polymers & polymer drug conjugates
            • Hydrogel nanoparticles
            • Dendrimers
            • Inorganic nanoparticles
          • Nanoshells
          • Nanotubes
          • Nanodevices
    • Europe
      • Germany
        • Germany Product Outlook (Revenue, USD Billion, 2013 - 2025)
          • Therapeutics
          • Regenerative medicine
          • In-vitro diagnostics
          • In-vivo diagnostics
          • Vaccines
        • Germany Application Outlook (Revenue, USD Billion, 2013 - 2025)
          • Clinical Oncology
          • Infectious diseases
          • Clinical Cardiology
          • Orthopedics
          • Others
        • Germany Nanomolecule Type Outlook (Revenue, USD Billion, 2013 - 2025)
          • Nanoparticles
            • Metal & Metal Oxide Nanoparticles
              • By Type
                • Gold Nanoparticles
                • Silver Nanoparticles
                • Iron Oxide Nanoparticles
                • Alumina Nanoparticles
                • Gadolinium Oxide Nanoparticles
                • Others
              • By Application
                • In-vivo Imaging
                • Targeted Drug Delivery
                • Proton Therapy
                • In-vitro assays
                • Cell & Phantom Imaging
            • Liposomes
            • Polymers & polymer drug conjugates
            • Hydrogel nanoparticles
            • Dendrimers
            • Inorganic nanoparticles
          • Nanoshells
          • Nanotubes
          • Nanodevices
      • The U.K.
        • U.K. Product Outlook (Revenue, USD Billion, 2013 - 2025)
          • Therapeutics
          • Regenerative medicine
          • In-vitro diagnostics
          • In-vivo diagnostics
          • Vaccines
        • U.K. Application Outlook (Revenue, USD Billion, 2013 - 2025)
          • Clinical Oncology
          • Infectious diseases
          • Clinical Cardiology
          • Orthopedics
          • Others
        • UK Nanomolecule Type Outlook (Revenue, USD Billion, 2013 - 2025)
          • Nanoparticles
            • Metal & Metal Oxide Nanoparticles
              • By Type
                • Gold Nanoparticles
                • Silver Nanoparticles
                • Iron Oxide Nanoparticles
                • Alumina Nanoparticles
                • Gadolinium Oxide Nanoparticles
                • Others
              • By Application
                • In-vivo Imaging
                • Targeted Drug Delivery
                • Proton Therapy
                • In-vitro assays
                • Cell & Phantom Imaging
            • Liposomes
            • Polymers & polymer drug conjugates
            • Hydrogel nanoparticles
            • Dendrimers
            • Inorganic nanoparticles
          • Nanoshells
          • Nanotubes
          • Nanodevices
    • Asia Pacific
      • Japan
        • Japan Product Outlook (Revenue, USD Billion, 2013 - 2025)
          • Therapeutics
          • Regenerative medicine
          • In-vitro diagnostics
          • In-vivo diagnostics
          • Vaccines
        • Japan Application Outlook (Revenue, USD Billion, 2013 - 2025)
          • Clinical Oncology
          • Infectious diseases
          • Clinical Cardiology
          • Orthopedics
          • Others
        • Japan Nanomolecule Type Outlook (Revenue, USD Billion, 2013 - 2025)
          • Nanoparticles
            • Metal & Metal Oxide Nanoparticles
              • By Type
                • Gold Nanoparticles
                • Silver Nanoparticles
                • Iron Oxide Nanoparticles
                • Alumina Nanoparticles
                • Gadolinium Oxide Nanoparticles
                • Others
              • By Application
                • In-vivo Imaging
                • Targeted Drug Delivery
                • Proton Therapy
                • In-vitro assays
                • Cell & Phantom Imaging
            • Liposomes
            • Polymers & polymer drug conjugates
            • Hydrogel nanoparticles
            • Dendrimers
            • Inorganic nanoparticles
          • Nanoshells
          • Nanotubes
          • Nanodevices
      • China
        • China Product Outlook (Revenue, USD Billion, 2013 - 2025)
          • Therapeutics
          • Regenerative medicine
          • In-vitro diagnostics
          • In-vivo diagnostics
          • Vaccines
        • China Application Outlook (Revenue, USD Billion, 2013 - 2025)
          • Clinical Oncology
          • Infectious diseases
          • Clinical Cardiology
          • Orthopedics
          • Others
        • China Nanomolecule Type Outlook (Revenue, USD Billion, 2013 - 2025)
          • Nanoparticles
            • Metal & Metal Oxide Nanoparticles
              • By Type
                • Gold Nanoparticles
                • Silver Nanoparticles
                • Iron Oxide Nanoparticles
                • Alumina Nanoparticles
                • Gadolinium Oxide Nanoparticles
                • Others
              • By Application
                • In-vivo Imaging
                • Targeted Drug Delivery
                • Proton Therapy
                • In-vitro assays
                • Cell & Phantom Imaging
            • Liposomes
            • Polymers & polymer drug conjugates
            • Hydrogel nanoparticles
            • Dendrimers
            • Inorganic nanoparticles
          • Nanoshells
          • Nanotubes
          • Nanodevices
    • Latin America
      • Brazil
        • Brazil Product Outlook (Revenue, USD Billion, 2013 - 2025)
          • Therapeutics
          • Regenerative medicine
          • In-vitro diagnostics
          • In-vivo diagnostics
          • Vaccines
        • Brazil Application Outlook (Revenue, USD Billion, 2013 - 2025)
          • Clinical Oncology
          • Infectious diseases
          • Clinical Cardiology
          • Orthopedics
          • Others
        • Brazil Nanomolecule Type Outlook (Revenue, USD Billion, 2013 - 2025)
          • Nanoparticles
            • Metal & Metal Oxide Nanoparticles
              • By Type
                • Gold Nanoparticles
                • Silver Nanoparticles
                • Iron Oxide Nanoparticles
                • Alumina Nanoparticles
                • Gadolinium Oxide Nanoparticles
                • Others
              • By Application
                • In-vivo Imaging
                • Targeted Drug Delivery
                • Proton Therapy
                • In-vitro assays
                • Cell & Phantom Imaging
            • Liposomes
            • Polymers & polymer drug conjugates
            • Hydrogel nanoparticles
            • Dendrimers
            • Inorganic nanoparticles
          • Nanoshells
          • Nanotubes
          • Nanodevices
    • MEA
      • South Africa
        • South Africa Product Outlook (Revenue, USD Billion, 2013 - 2025)
          • Therapeutics
          • Regenerative medicine
          • In-vitro diagnostics
          • In-vivo diagnostics
          • Vaccines
        • South Africa Application Outlook (Revenue, USD Billion, 2013 - 2025)
          • Clinical Oncology
          • Infectious diseases
          • Clinical Cardiology
          • Orthopedics
          • Others
        • South Africa Nanomolecule Type Outlook (Revenue, USD Billion, 2013 - 2025)
          • Nanoparticles
            • Metal & Metal Oxide Nanoparticles
              • By Type
                • Gold Nanoparticles
                • Silver Nanoparticles
                • Iron Oxide Nanoparticles
                • Alumina Nanoparticles
                • Gadolinium Oxide Nanoparticles
                • Others
              • By Application
                • In-vivo Imaging
                • Targeted Drug Delivery
                • Proton Therapy
                • In-vitro assays
                • Cell & Phantom Imaging
            • Liposomes
            • Polymers & polymer drug conjugates
            • Hydrogel nanoparticles
            • Dendrimers
            • Inorganic nanoparticles
          • Nanoshells
          • Nanotubes
          • Nanodevices

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2013 to 2025
  • Market estimates and forecast for product segments up to 2025
  • Regional market size and forecast for product segments up to 2025
  • Market estimates and forecast for application segments up to 2025
  • Regional market size and forecast for application segments up to 2025
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.